Qscan Services Pty Ltd

Qscan Services Pty Ltd, based in Australia, provides comprehensive medical imaging services, including X-ray, CT scans, and MRI. They utilize advanced technology to meet the diagnostic needs of healthcare providers and patients alike. Founded in 2006 in Australia, Qscan Services Pty Ltd specializes in medical imaging services. The company was acquired in October 2020 when a consortium led by Morrison & Co and Infratil purchased a 75% majority stake for AUD 730 million from Quadrant Private Equity.

Gary Shepherd serves as CEO, guiding the company through its growth phases. The most recent major deal occurred in 2020, and the total amount raised by the company stands at AUD 289. 60 mn. Qscan specializes in a wide array of medical imaging services, leveraging advanced technology to meet the diagnostic needs of patients and healthcare providers.

Their core offerings include X-ray, ultrasound, CT scans, MRI, PET scans, nuclear medicine, and mammography, all designed to provide high-quality imaging for medical analysis and treatment planning. The company focuses on delivering premium patient care, ensuring timely report delivery and seamless access to imaging resources via electronic platforms. Qscan operates within various geographical markets, including Brisbane and the Gold Coast, catering to a diverse clientele that includes healthcare professionals, hospitals, and patients requiring diagnostic imaging solutions. The firm is committed to supporting its referrers with comprehensive assistance, showcasing their dedication to both patient outcomes and healthcare partnerships.

In the most recent financial year of 2021, Qscan reported a revenue of AUD 51,548,953. 50 and an EBITDA of AUD 18,807,362. 40. Their revenue model primarily involves direct transactions with healthcare providers and patients seeking diagnostic imaging services, with structured transactions where referrers utilize Qscan's offerings for patient imaging needs.

Following the recent acquisition, Qscan Services Pty Ltd plans to utilize the AUD 330 million cash equity injection from Infratil to support growth initiatives. This investment will assist in expanding their services and potentially developing new imaging products. The company is focused on enhancing its presence in existing markets and exploring opportunities in new geographic regions. No specific details regarding upcoming products or targeted regions have been disclosed.